PHARMACEUTICAL PREPARATIONS GENETICALLY DRIVEN

Brand Owner (click to sort) Address Description
EDIT Saliogen Therapeutics, Inc. 245 First Street, 18th Floor Cambridge MA 02142 Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes;Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research;
EXACT DNA INTEGRATION BY TRANSPOSITION Saliogen Therapeutics, Inc. 245 First Street, 18th Floor Cambridge MA 02142 Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; nucleic acids, and nucleotides for medical and veterinary purposes;Nucleic acids, and nucleotides for scientific and research use in the fields of drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations soley for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences soley for use in the field of scientific research;DNA INTEGRATION BY TRANSPOSITION;
EXACT DNA INTEGRATION TECHNOLOGY Saliogen Therapeutics, Inc. 245 First Street, 18th Floor Cambridge MA 02142 Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; nucleic acids, and nucleotides for medical and veterinary purposes;Nucleic acids, and nucleotides for scientific and research use in the fields of drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations soley for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences soley for use in the field of scientific research;DNA INTEGRATION TECHNOLOGY;
GENE CODING Saliogen Therapeutics, Inc. 245 First Street, 18th Floor Cambridge MA 02142 Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes;Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research;
SALIOGASE Saliogen Therapeutics, Inc. 245 First Street, 18th Floor Cambridge MA 02142 Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes;Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research;
SALIOGEN Saliogen Therapeutics, Inc. 245 First Street, 18th Floor Cambridge MA 02142 Pharmaceutical preparations for genetically driven disorders, neurological, gastrointestinal, metabolic, immunological, dyslipidemias musculoskeletal, oncological disorders and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes;Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research;Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.